Marcy l’Etoile, France – bioMérieux, a world leader in the field of in vitro diagnostics, announces the opening of its 41st commercial subsidiary in Hanoi, Vietnam. This wholly owned company in Vietnam will be bioMérieux’s 7th subsidiary in Southeast Asian emerging countries.
In Vietnam, bioMérieux has a leadership position in automated bacterial identification and susceptibility testing. This success has been built through a long-standing collaboration with distributors, who will continue to work with bioMérieux.
“Our extensive international commercial network is a key asset for our development,” said Thierry Bernard, bioMérieux Corporate Vice President of Global Commercial Operations. “Following our 2012-2015 roadmap, we have created two commercial subsidiaries in emerging countries this year, in Malaysia and now in Vietnam. Our strong, well-structured operations in the region enable us to address customer needs and contribute to improving public health.”
The in vitro diagnostics market is expanding rapidly in Vietnam. bioMérieux intends to reinforce its clinical microbiology business through a broad offering of manual and automated solutions. The country offers excellent growth opportunities for the Company’s VIDAS® immunoassay range, which is being enhanced by the launch of a new generation system. Industrial applications will be another development area.
bioMérieux will also bring its expertise to Vietnamese laboratories, offering training programs adapted to their needs.
Download
- Filename
- PR_bioMerieux_Vietnam_Subsidiary_201212041.pdf
- Size
- 132 KB
- Format
- application/pdf